| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/19/2000 | EP0972040A1 Human gtp binding protein |
| 01/19/2000 | EP0972038A1 Human tumorigenesis associated protein, htap |
| 01/19/2000 | EP0972036A2 Prion propagation inhibition by dominant-negative prion protein mutants |
| 01/19/2000 | EP0972035A1 Human tumor suppressor |
| 01/19/2000 | EP0972033A1 Modulators of the function of receptors of the tnf/ngf receptor family |
| 01/19/2000 | EP0972032A2 Peptides for the treatment of systemic lupus erythematosus |
| 01/19/2000 | EP0972030A2 70human secreted proteins |
| 01/19/2000 | EP0972028A1 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
| 01/19/2000 | EP0972027A1 Human c5a-like receptor |
| 01/19/2000 | EP0972025A1 I-flice, a novel inhibitor of tumor necrosis factor receptor-1 and cd-95 induced apoptosis |
| 01/19/2000 | EP0972024A1 A tumor suppressor designated ts10q23.3 |
| 01/19/2000 | EP0972023A2 Fc RECEPTORS AND POLYPEPTIDES |
| 01/19/2000 | EP0972022A2 Polynucleotides and polypeptides encoding receptors |
| 01/19/2000 | EP0972021A1 Extracellular/epidermal growth factor like protein |
| 01/19/2000 | EP0972020A1 Insulin-like growth factor agonist peptides |
| 01/19/2000 | EP0972015A1 Enzyme having s-adenosyl-l-homocysteine hydrolase (ahcy) type activity |
| 01/19/2000 | EP0972011A1 Cyclin-dependent protein kinase |
| 01/19/2000 | EP0971959A1 Humanized antibodies and methods for forming humanized antibodies |
| 01/19/2000 | EP0971957A1 Polypeptide with appetite regulating activity |
| 01/19/2000 | EP0971951A1 Diagnosis of colorectal cancer and proteins and antibodies for use therein |
| 01/19/2000 | EP0971741A1 Use of avian antibodies |
| 01/19/2000 | EP0971740A2 Fibronectin binding protein compositions, antibodies thereto, and methods of use |
| 01/19/2000 | EP0971727A1 Production process for intravenous immune serum globulin and resultant product |
| 01/19/2000 | EP0971726A1 Peptides for inhibiting retroviruses |
| 01/19/2000 | EP0851870A4 Colon cell and colon cancer cell associated nucleic acid molecules, protein and peptides |
| 01/19/2000 | EP0814826A4 Compositions and methods for reducing adhesiveness of defective red blood cells |
| 01/19/2000 | EP0625989B1 Dna sequences encoding novel growth/differentiation factors |
| 01/19/2000 | EP0587873B1 Process for the production of cells infected by a multiple sclerosis associated virus |
| 01/19/2000 | EP0552266B1 Preparation of chimaeric antibodies using the recombinant pcr strategy |
| 01/19/2000 | EP0515536B1 Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules |
| 01/19/2000 | CN1242047A Compound and methods for diagnosis of tuberculosis |
| 01/19/2000 | CN1242045A Immunotherapy and improved vaccines |
| 01/19/2000 | CN1242043A Receptor ligand VEGF-C |
| 01/19/2000 | CN1241574A Liver cancer-resisting monoclone antibody HAb25 and its single stranded antibody and bifunctional antibody |
| 01/19/2000 | CN1241573A Liver cancer murine monoclone antibody without endogenous immunoglobulin and its preparation and application |
| 01/18/2000 | US6015938 Osteoprotegerin |
| 01/18/2000 | US6015897 For conjugation to ligand/antiligand pair and use in delivery of therapeutic or diagnostic agent to targeted site |
| 01/18/2000 | US6015884 Soluble divalent and multivalent heterodimeric analogs of proteins |
| 01/18/2000 | US6015883 Amino acid sequence of purified chemokine polypeptide; treatment of immune deficiency diseases, autoimmune diseases, allergies or asthma; anticarcinogenic/antiinflammatory/ antiarthritic agents |
| 01/18/2000 | US6015882 Amino acid sequence of antigen gp900 detected at the surface of cryptosporidium sporozoites or merozoites; for antiprotozoa agents |
| 01/18/2000 | US6015876 Treating medical and laboratory equipment and supplies, suspensions, solutions, blood, blood products, and tissues by contacting with viricidal protein, peptide, or conjugate |
| 01/18/2000 | US6015702 Nucleotide and amino acid sequences; for diagnosis, prevention and treatment of neoplastic, developmental, immune and nervous system disorders; anticarcinogenic/antitumor/ antisense agents |
| 01/18/2000 | US6015695 Immunoglobulins devoid of light chains |
| 01/18/2000 | US6015693 Recombinant production of soluble TGF-β-binding endoglin polypeptides |
| 01/18/2000 | US6015689 Amino acid sequences of protein controlling sensitivity of fungus to fungicide; for diagnosis and treatment of mycoses |
| 01/18/2000 | US6015688 Transferrin receptor genes |
| 01/18/2000 | US6015687 Apoptosis-modulating proteins, DNA encoding the proteins and methods of use thereof |
| 01/18/2000 | US6015682 Factors which modify gene transcription and methods of use therefor |
| 01/18/2000 | US6015680 Human lung adenocarcinoma-related monoclonal antibody and immunoassay method which uses the same |
| 01/18/2000 | US6015678 Method for detection of a polynucleotide encoding protein kinase C inhibitor-homolog |
| 01/18/2000 | US6015677 Assay methods using DNA encoding mammalian phosphodiesterases |
| 01/18/2000 | US6015572 Glial cells with neurotropic factors for nerve damage |
| 01/18/2000 | US6015562 Antitumor agents |
| 01/18/2000 | US6015560 Antibody recognizing endothelial cell ligand for leukocyte CR3 |
| 01/18/2000 | US6015559 Fas antagonists |
| 01/18/2000 | US6015558 Treatment of insulin resistance in obesity linked type II diabetes using antagonists to TNF-α function |
| 01/18/2000 | US6015557 Tumor necrosis factor antagonists for the treatment of neurological disorders |
| 01/18/2000 | US6015556 Cytotoxic drug therapy |
| 01/18/2000 | US6015555 Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates |
| 01/18/2000 | US6015542 Radioimmunotherapy of lymphoma using anti-CD20 antibodies |
| 01/13/2000 | WO2000002051A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | WO2000002050A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | WO2000001822A1 Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof |
| 01/13/2000 | WO2000001821A2 Neurotransmission associated proteins |
| 01/13/2000 | WO2000001818A1 Human emr1-like g protein coupled receptor |
| 01/13/2000 | WO2000001817A2 Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods |
| 01/13/2000 | WO2000001815A2 Neurotrophic factors |
| 01/13/2000 | WO2000001811A1 Kv6.2, A VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT |
| 01/13/2000 | WO2000001807A1 Serine protease-specific monoclonal antibody and utilization thereof |
| 01/13/2000 | WO2000001732A2 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 01/13/2000 | WO2000001728A1 Galectin 11 |
| 01/13/2000 | WO2000001724A1 Microsporidium polar tube proteins, nucleic acids coding for said proteins and their uses |
| 01/13/2000 | WO2000001713A2 Diacylglycerol acyl transferase proteins |
| 01/13/2000 | WO2000001410A1 Methods of inhibiting proliferative diseases by inhibiting tgf-beta mediated angiogenesis |
| 01/13/2000 | WO1999060125A3 Secreted proteins |
| 01/13/2000 | WO1999057241A3 Myelin basic protein peptides and uses thereof |
| 01/13/2000 | WO1999053047A3 Porcine adenovirus type 3 genome |
| 01/13/2000 | DE19831061A1 Reducing aggregate content of protein preparation, especially virus-inactivated therapeutic plasma protein or chemically modified protein preparation |
| 01/13/2000 | CA2402839A1 Galectin 11 |
| 01/13/2000 | CA2336739A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | CA2336406A1 Galectin 11 |
| 01/13/2000 | CA2333919A1 Microsporidium polar tube proteins, nucleic acids coding for said proteins and their uses |
| 01/13/2000 | CA2332573A1 Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods |
| 01/13/2000 | CA2332309A1 Neurotransmission associated proteins |
| 01/13/2000 | CA2331829A1 Kv6.2, a voltage-gated potassium channel subunit |
| 01/13/2000 | CA2331771A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 01/13/2000 | CA2331394A1 Human emr1-like g protein coupled receptor |
| 01/12/2000 | EP0971034A1 Process for preparing antibody molecules |
| 01/12/2000 | EP0971033A2 Test and model for Alzheimer's disease |
| 01/12/2000 | EP0970377A1 Diagnosis of epithelial cell abnormalities |
| 01/12/2000 | EP0970372A1 Assay for disease related conformation of a protein |
| 01/12/2000 | EP0970243A1 Diagnosis and treatment of glaucoma |
| 01/12/2000 | EP0970231A1 Expression of herbicide-binding polypeptides in plants to produce herbicide tolerance |
| 01/12/2000 | EP0970227A1 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors |
| 01/12/2000 | EP0970223A1 Serine/threonine protein kinase |
| 01/12/2000 | EP0970219A1 A porin gene from campylobacter jejuni, related products and uses thereof |
| 01/12/2000 | EP0970217A2 Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use |
| 01/12/2000 | EP0970215A1 Suppressor of cytokine signaling |
| 01/12/2000 | EP0970213A2 Death domain containing receptor 5 |
| 01/12/2000 | EP0970212A1 Secreted salivary zsig32 polypeptides |